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for quality improvement
Sara DahlinAbstract
Background: Visualization is important to aid practitioners in understanding local care processes and drive quality
improvement (QI). Important aspects include timely feedback and ability to plot data over time. Moreover, the
complexity of care also needs to be understood, as it affects the variation of care processes. However, there is a
lack of QI methods visualizing multiple, related factors such as diagnosis date, death date, and cause of death to
unravel their complexity, which is necessary to understand processes related to survival data. Lexis diagrams
visualize individual patient processes as lines and mark additional factors such as key events. This study explores
the potential of Lexis diagrams to support QI through survival data analysis, focusing on feedback, timeliness, and
complexity, in a gynecological cancer setting in Sweden.
Methods: Lexis diagrams were produced based on data from a gynecological cancer quality registry (4481
patients). The usefulness of Lexis diagrams was explored through iterative data identification and analysis through
semi-structured dialogues between the researcher and domain experts (clinically active care process owners) during
five meetings. Visualizations were produced and adapted by the researcher between meetings, based on the
dialogues, to ensure clinical relevance, resulting in three relevant types of visualizations.
Results: Domain experts identified different uses depending on diagnosis group and data visualization. Key results
include timely feedback through close-to-real-time visualizations, supporting discussion and understanding of
trends and hypothesis-building. Visualization of care process complexity facilitated evaluation of given care.
Combined visualization of individual and population levels increased patient focus and may possibly also function
to motivate practitioners and management.
Conclusion: Lexis diagrams can aid understanding of survival data, triggering important dialogues between care
givers and supporting care quality improvement and new perspectives, and can therefore complement survival
curves in quality improvement.
Keywords: Quality improvement, Survival data, Feedback, Timeliness, Complexity, Lexis diagramBackground
The aim of quality improvement (QI) is “to make
changes that will lead to better patient outcomes
(health), better systems performance (care) and better
professional development (learning)” ( [1], p., 2). Im-
provement efforts should be guided by data, which can
enable practitioners to understand how their local pro-
cesses vary and take relevant action on that basis [2, 3].
As process variation is constantly affected by a wide
range of factors, both within and outside of the© The Author(s). 2020 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
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Technology, 412 96 Gothenburg, Swedenpractitioners’ control [3], feedback gained by following
data over time is needed to enable an understanding of
the process [4], preferably in real time [5]. Data
visualization enables analysis and sensemaking by do-
main experts based on their knowledge and experience
[6, 7]. They identify and observe datapoints, discover
patterns, and compare the results to their prior under-
standing, drawing inferences and building hypotheses
[8]. This may answer questions such as “Are we on
track?” “Is something negative happening that we need
to address?” “or even “Is the process improving?” Such
exploration may later be followed by confirmatory statis-
tical analysis [9]. Data visualization also has the purposele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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basis for discussion between stakeholders for QI [11].
Performance-related feedback has also been shown to be
important for motivating staff, regardless of whether it
indicates a need for improvement or not [12].
To enable local understanding, methods visualizing
local process change are used in several healthcare
settings (see e.g. [13]). However, one area in which
improvements could be made in the visual representa-
tion of data for QI purposes is survival data analysis.
Such data are often analyzed through survival curves
and used for evaluating improvement efforts (see e.g.
[14]), but survival curves have another purpose; they
contribute to “global knowledge” useful in (e.g.) med-
ical research such as clinical trials of new treatments,
or, as in Dahm-Kähler et al. [15], showing that
centralization of surgery improves survival on a popu-
lation level. Kaplan–Meier analysis is the most popu-
lar type of survival data analysis [16], resulting in a
survival curve plot (exemplified in Fig. 1a) featuring
time since an event on the x-axis and a survival prob-
ability measure on the y-axis, such as survival rate
[15] or cumulative survival [16], presenting the esti-
mated survival rate of (e.g.) a patient group with a
particular diagnosis over a certain time interval since
the starting event. For further information about
Kaplan–Meier curves, see Jager et al. [16]. Its purpose
is thus not to support local process understanding
and action for QI and due to the need for large sam-
ple sizes and aggregation of data, other methods are
needed to ensure timeliness and gaining feedback by
following data over time, contributing to local
improvements.Fig. 1 Examples of different visualizations. 1a. Survival curve comparing tw
from Elsevier. 1b. Lexis diagram, presenting data of four hypothetical patien
(y = 0) and continuing upwards until patient’s death, or extending to right
angle reflects equal time passing along both time axes in the Lexis diagram
occurring between diagnosis and deathTo follow local changes over time related to (e.g.) can-
cer care processes, survival data documented in health
information systems may be usefully input into methods
supporting understanding of local process changes.
Survival data typically include several important
factors, such as time of diagnosis, time of death and
cause of death, which may need to be understood
simultaneously, as they together reflect care process
complexity. Notably, the level of complexity in a
(care) system depends on the number of components
and their interrelatedness [17], and non-linearity also
characterizes complex system behavior [18]; studying
relevant interrelatedness between components within
the care system may support understanding of the
system [17] and thus aid local improvement action [2,
3]. Characterizing components’ interrelatedness be-
comes necessary to unravel the system’s complexity
[17], and domain experts may in this way be
supported in their understanding of local care process
complexity and thereby guided into QI efforts [19].
To analyze such data, focus need to be set on under-
standing and visualizing the complexity of several
process-related factors for feedback purposes. Specific-
ally, as noted by Jiang et al. [20], combined
visualization of aggregated, population-based data and
patient-level raw data can powerfully reveal relevant
patterns. QI literature gives limited attention to
methods visualizing multiple process-related factors
on an individual level over time and in a timely man-
ner. Graphical excellence, being “that which gives to
the viewer the greatest number of ideas in the short-
est time with the least ink in the smallest space…tell-
ing the truth about the data” ( [21], p., 51), may beo cohorts. Reprinted from Dahm-Kähler et al. [15], with permission
ts, each patient represented by a lifeline starting on diagnosis date
border if patient is alive at data extraction. The lifelines’ 45-degree
. Dots represent time of death, and crosses show other events
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bring domain experts effective feedback on their
process. Through their domain expertise, they can
make sense of data lacking statistical significance, and
thereby build understanding which may support them
in action.
Consequently, new methods addressing feedback
(through following data over time) and visualizing com-
plexity while also ensuring timeliness are preferred in
the analysis of survival data for QI. Lexis diagrams is
one such possible method, used to identify joint effects
of age, period, and cohorts [22–24], and serve as a pos-
sible complement to subsequent statistical survival ana-
lysis [25, 26]. In its basic configuration, a Lexis diagram
visualizes individual lifelines along two time axes: calen-
dar time and age or year since diagnosis [27–29], where
the lines extends in a 45-degree angle as time passes
along both x and y axes. Figure 1b shows a basic Lexis
diagram with hypothetical patients.
Lines and markings can be differently colored or
shaped to represent different attributes [30, 31], for in-
stance, line colors representing diagnoses; marking
shapes representing care process events, and marking
colors representing event attributes. New data (lines/pa-
tients or markings) can be continuously added, support-
ing timeliness in analysis. Lexis diagrams can for
example be analyzed by counting markings, such as dots
[30] or lines, across a section of the diagram [32], to
identify patterns. Together, this versatile visualization
may reveal the complex pattern of events, time between
events and attribute data, that may enhance understand-
ing [33]. Kaplan–Meier survival curves and Lexis dia-
gram are compared in Table 1.
Lexis diagrams have been applied in several ways, such
as for advanced graphical display of individual life histor-
ies [30] and population-level mortality dynamics [34].
With potential to elicit feedback by (e.g.) presenting
trends in data [35], ensure timeliness through real-time
monitoring [32], and visualize complexity through the
use of different colors, markings, and time axes [33],
they may help practitioners understand care given and
improve actionable survival data analysis. However,
despite the epidemiology–QI link [36], and the use of
Lexis diagrams to understand survival epidemiologically
(see e.g. [37, 38, 39]), few studies have considered Lexis
diagrams as a QI aid (see for example [32]).
As the combination of Lexis diagrams, survival data,
and support for QI seems still unaddressed, this studyTable 1 Comparison between Kaplan–Meier curves and Lexis diagra
Method Data Process changes Lev
Kaplan–Meier Aggregated data Before- and after Glo
Lexis diagram Raw data Followed over time Locexplores the potential of Lexis diagrams to support QI




The study context is gynecological cancer in Western
Sweden. Survival data analysis is highly relevant to can-
cer diagnoses, since most cancer types are still life-
threatening, and patients may be saved by improved
care. This diagnosis group also received additional atten-
tion through the “Cancer Moonshot” program launched
in 2016, through which quality improvement and
learning healthcare systems contribute via continuous
monitoring of clinical practice [40]. “Cancer Moonshot”
aims to progress precision medicine—personalized care
based on characteristics such as genetic differences [40].
With increased complexity of care, potentially resulting
in small patient sample sizes [41], visualization through
Lexis diagrams in combination with domain expert
understanding could support cancer care quality
improvement.
In this study, gynecological cancer data are used.
Gynecological cancer diagnoses strike about 2800
women yearly in Sweden, with relatively low mortality,
as noted, except for ovarian cancer. In Sweden, national
quality registries for gynecological cancer are handled by
Regional Cancer Centre West (RCC West). The ovarian
cancer registry started in 2008, the uterine corpus cancer
registry in 2010 and the cervical cancer registry in 2011.
Designated process owners, who are clinically active
physicians with great practical knowledge, are “owning”
the process by being responsible for developing the care
pathway for a specific cancer diagnosis, making them in-
valuable for quality improvement collaborations involv-
ing method assessment and development.
Reasons for choosing gynecological cancer are several.
First, process owners are engaged and interested in
collaboration regarding new methods. Second,
gynecological cancer sub-diagnoses (ovarian, cervical,
corpus) exhibit low incidence and/or high survival, ex-
pected to render small data sets, well suited for Lexis
diagram [30]. Third, the three diagnosis subgroups have
different care processes and patient characteristics, yield-
ing a broader picture of Lexis diagram usefulness.
Fourth, the gynecology cancer quality registry inm
el Data variables Statistical analysis Data set size
bal Single variable Yes Large
al Multiple variables No Small
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ing risk of bias from missing data.
Research process
The research process is presented in Fig. 2 below; it is
similar to how Street et al. [42] addressed method devel-
opment in a collaborative environment.
Setting the collaboration
Exploration of data for QI purposes demands good un-
derstanding of the visualization by those involved; there-
fore, a simple graphic display is preferred [4, 43]. Too
much information may be difficult to grasp, so only rele-
vant data should be included, to keep the illustration as
simple as possible [21]. Thus, a collaboration entailing
both domain expertise and method knowledge was ne-
cessary. The collaboration entailed the researchers and
the four regional process owners for gynecological can-
cer in Western Sweden, being active physicians (three
surgeons and one oncologist). The process owners con-
tributed with medical and local data expertise to ensure
relevant visualization and avoid misinterpretations. The
researcher presented the methodological ideas to the
process owners and supported them with methodo-
logical knowledge during method evaluation.
Data identification and extraction
Iterative data identification and analysis was performed
through semi-structured dialogues during five meetings
including the researcher and 1–4 process owners de-
pending on availability. At one meeting, the statistician
at RCC West, responsible for data extraction, wasFig. 2 The collaborative research process with the researcher’s role
on the left and process owner’s role on the rightpresent to help answer questions regarding relevant vari-
ables. Meetings lasted 60–150 min each and were audio-
recorded.
Relevant data and subgroups were identified by
process owners and extracted from the Swedish quality
register for gynecological cancer (sub-registers ovarian
cancer, cervical cancer, corpus cancer) over the full
length of the cancer registries (diagnosis date from
2008-01-01 for ovarian cancer , 2011-01-01 for cervical
cancer, and 2010-01-01 for corpus cancer until 2016-12-
31 for all diagnoses). Patients were followed until death
or until the data extraction day (2018-11-17). Additional
factors included surgery date, relapse date, and cause of
death. Stratification of data was based on sub-diagnosis
group and tumor severity, the main reasons for differ-
ences in care processes, such as surgery or radiation.
Tumor severity was classified by International Feder-
ation of Gynecology and Obstetrics (FIGO) stages I
(least severe) to IV (most severe). FIGO stages are fur-
ther divided into A–C to reflect tumor spread, resulting
in (e.g.) FIGO stage IVB. Data preparation included
clearing doublets for patients with several surgeries; the
first surgery date (often primary surgery) was kept. Add-
itionally, 20 patients who moved abroad were excluded
due to unresolved lifelines. In summary, 1924 ovarian
cancer patients, 511 cervical cancer patients, and 2046
corpus cancer patients were included.
Data visualization using Lexis diagram
Lexis diagrams of survival data were plotted in R using
the Epi package [31]. Dates of diagnosis, surgery, relapse,
and death were plotted using lifelines. Different-colored
lines and different-colored and -shaped events happen-
ing during the patients’ lifetime were used to enhance
visualization of care complexity represented by (e.g.)
cause of death. It was important to include all patients,
regardless of survival, to avoid bias.
Data analysis
Lexis diagrams were presented to process owners at each
dialogue meeting, visualized according to expected needs
from the last meeting. The process owners analyzed data
as they saw fit in order to find relevant patterns. This in-
cluded eye-balling the graph for overall trends, counting
dots and lines, or analyzing sections of the diagram. It
was clarified to process owners that the patterns may in-
dicate trends but that this does not imply statistical
significance. The scope of relevant data was revised
based on insights gained during analysis, leading to fur-
ther updates of diagrams between meetings. Each meet-
ing ended with an action plan for the next step of
visualization; this iteration continued until process
owners felt that visualizations reflected the important
factors for their diagnoses in an understandable way;
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of use and perceived usefulness to support QI are im-
portant factors for new QI methods, since both reflect
behavioral intention to use the method [44]. Therefore,
questions regarding usefulness and ease of use were in-
cluded in the dialogues. Focus of discussions otherwise
lay on clinical interpretation, connection to QI, and
graphical representation.
Results
Sample diagrams are presented to illustrate key results
and different features and usage across the three cancers,
to show different ways to use the diagrams depending
on data relevance, with emphasis on feedback, timeli-
ness, and visualizing complexity.
Ovarian cancer: presenting data in survival curves and
Lexis diagrams, respectively
To support understanding, Fig. 3 present a Lexis dia-
gram including a small sample size and focusing on
cause of death only. The data are survival data forFig. 3 A Lexis diagram of the patients with ovarian and tubular cancer FIG
surgery. Incidence per year is equal to the number of patients in the cohorovarian and tubular cancer FIGO stages III–IV in pa-
tients diagnosed from 2008-01-01 to 2016-12-31 that
underwent delayed surgery. The patients were
followed until death or data extraction day 2018-11-
17. Each line represents a patient, entering the
diagram on the x-axis on the date of diagnosis, then
follows along the line until either death (line ending
with a dot) or extraction date (line stretching to the
right border). Each dot represents one death, and the
different colors of death events represent causes of
death, as presented in the legend. The incidence per
year for this patient group is presented below the x-
axis. From eye-balling the data, there seem not to be
any clear trends regarding survival. However, one im-
portant and positive conclusion is that this cohort has
no treatment-complication-related deaths (which
would have been represented by light green dots).
To build up the understanding of complexity, Fig. 4
show data on all ovarian and tubular cancer FIGO stages
III–IV patients that underwent surgery, diagnosed from
2008-01-01 to 2016-12-31. The markings show some ofO stages III–IV, diagnosed in years 2008–2016, undergoing delayed
t each year
Fig. 4 All patients diagnosed with ovarian and tubular cancer FIGO stages III–IV, 2008–2016. Incidence per year is equal to the number of
patients in the cohort each year. Note that the visualization is better displayed on the computer screen, see online version
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dividual lifelines are plotted.
As above, the color of the end-line dot for each patient
symbolizes cause of death, while the ¤ mark represents
relapse date and the cross represents surgery date (see
figure legend). The separation between primary surgery
and delayed primary surgery was chosen because of
different care processes: delayed surgery is preceded by
chemotherapy to shrink the tumor before surgery, while
in direct primary surgery, chemotherapy is given post-
surgery. These subgroups are here presented together,but could also have been presented in separate Lexis dia-
grams, as in Fig. 3. Noteworthy, some of the same data
(diagnosis date 2008-01-01–2013-12-31) have previously
been used by the process owners in survival curve ana-
lysis form, as published in Dahm-Kähler et al. [15], to
evaluate centralizing surgery from regional hospitals to
the main university hospital in Region Västra Götaland,
as of January 2011 (see Fig. 1a). That data analysis con-
tributed to “global knowledge” on medical improvement
by showing significantly lower mortality following
centralization. Although survival curves and Lexis
Dahlin BMC Medical Informatics and Decision Making            (2020) 20:7 Page 7 of 13diagrams have different purposes, process owners are ac-
customed to analyzing survival data using survival curves
and thus initially compared the two methods with each
other, as seen in some of the following quotes.
Feedback and timeliness
The ability to continuously add new patients is an
advantage of Lexis diagrams. One process owner gave
the following first impression regarding gaining feedback
from following the care process over time:
“It [the Lexis diagram] is continuous, enabling closer
to real-time monitoring… It is very useful since it is
very illustrative…. One sees how the deaths are spread
over the years and one sees when the relapses are com-
ing. So, it is a very efficient way to illustrate [survival
data]…. One gets faster feedback than waiting for five-
years survival analysis.”
– Process owner 1
Since different interventions have been made continu-
ously in the care process, potential root causes need fur-
ther attention, but Lexis diagrams opened up discussions
around improvement efforts, future events, and how to
proceed with investigations. For example, counting light
green dots revealed that in the cohort diagnosed during
the first 4 years, 2008–2011, there were five deaths due
to treatment, but only one in the cohort diagnosed in
2012 and onwards, covering 5 years. As noted by a
process owner, increase in green dots in Fig. 4 during
real-time follow-up would represent a timely alarm that
there is a problem with the care process. Generally,
Lexis diagrams do not rely on any specific rules or
thresholds for when to act; rather, it is driven by domain
expertise. As treatment-related death should preferably
never happen, a single green dot could be enough to
trigger further investigation and action. Counting dots in
Fig. 4 is somewhat difficult, and to facilitate feedback on
treatment-related deaths (that is, the counting of light
green dots), a Lexis diagram presenting only lifelines and
cause of death dots, as in Fig. 3, could be produced.
Visualizing care complexity also highlighted potential
problems and raised questions concerning data quality,
specifically the trustworthiness of the light green dots in
Fig. 4. Cause of death is sometimes hard to define, an
example being heart failure, which may be a conse-
quence of the very tough cancer treatment, in turn a
consequence of the cancer disease; any of these causes
of death (heart failure, treatment-related death, death
due to cancer) may have been chosen as the cause of
death by the pronouncing physician. Treatment-related
deaths seemed to happen close to surgery, but since
2014 (see Fig. 4), there have been very few deaths closeto surgery, indicating a low risk of treatment-related
deaths being registered as any other cause of death. This
discussion highlights the potential of Lexis diagrams to
drive data quality improvements.
Another aspect of feedback highlighted as important
was visualization of surviving patients. Lexis diagrams
like the ones in Figs. 3 and 4 present surviving patients
too, represented by the lifelines stretching until the ex-
traction date. This use of Lexis diagram visualization for
motivation was reflected upon by two process owners:
“There are rather many patients alive then [after 8–10
years].”
– Process owner 2
“Yes, and this is still for FIGO stages III and IV.…
They are many. This [visualization] I would like to
show our resident physicians [who often] lose faith and
believe that everyone dies.”
– Process owner 3
“Exactly! I need to remind our specialist physicians
about that also sometimes.… Because you meet those
that die, those are the ones you remember and work
with, isn’t it? Those [surviving] being home, you never
meet again.”
– Process owner 2Complexity
Process owners perceived the options to color both lines
and markings as highly useful as they allowed consider-
able information to be comprehensibly included. The
use of Lexis diagrams for visualizing care complexity
was contrasted with the use of survival curves by one
process owner, as survival curves represent the primary
method they use:
“They are a rather blunt tool, the survival curves,
because it shows patients on group level all the time
and who is it then that we lose, since they die? We
only get information about survivals, so to say. And
then one realizes that the other ones have died. And is
that the old patients, or who is it? Can one find
subgroups from which we can learn how to take better
care of them? …. [Presenting more factors in Lexis
diagrams] may lead to a hypothesis which needs to be
tested in a larger sample [using e.g. survival curves].
But here at least we see that something is happening.”
– Process owner 4
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poses and complementary use of survival curves and
Lexis diagrams, with regards to the explored purpose of
evaluating improvement efforts:
“This is another thing [than survival curves]…it is
another way of thinking if we want to see that we
made significant difference. Then we need to use the
statistical methods. But to see if one is on the right or
wrong track, that indication is maybe possible to get
along the way a bit earlier since one can visualize the
process. First [with Lexis diagram], we can see if we
are on the right track, then, [with statistical methods]
we can prove that we are on the right track.”
– Process owner 1
Thus, the findings verify that Lexis diagrams cannot
replace survival curves, but can serve as a complement
to give stakeholders feedback before statistical analysis.
Another result on visualization of care complexity is
that the diagrams were perceived as somewhat unpeda-
gogical, despite considerable work invested by the re-
searcher in finding good contrasts between colors and
markings. New users may need introductory education
to work with the diagrams, but after that, including sev-
eral factors should be no problem. In addition, when re-
ducing the diagram to only include causes of death,
process owners missed additional information from re-
lapses, etc.; when the basic concept of the Lexis diagram
is understood, the “messiness” may be bearable if the
complexity visualized in the diagram is understandable.
Cervical cancer: using age as a time axis
One strength of Lexis diagrams is to present data along
several time axes. In this example, age is used on an add-
itional time axis to diagnosis date time axis.
Timeliness
Cervical cancer is rare in Sweden owing to successful
screening [45]. This is reflected in Fig. 5a, where only
about 20 patients were diagnosed with FIGO stage
IB2–IIB a year and even fewer died. This means it
takes years to collect enough survival data to statisti-
cally analyze effects of care for subgroups, meaning
long lead times for feedback on care processes
through survival curves.
Feedback by following data over time
Age is an interesting factor for cervical cancer pa-
tients. Older patients are often fragile, and the treat-
ment is very aggressive. To understand the relation
between survival length and patient age, another Lexis
diagram was plotted, with patient age on the y-axisinstead of years since diagnosis; see Fig. 5b. Contra-
dicting the process owner’s perceived clinical experi-
ence, it appeared that age seemed to have had little
to do with the deceased’s length of survival in this
dataset; indeed, two of three patients who were 90 or
older survived for several years and one of them died
tumor free from another cause. As with any trend
identified, however, such relations need to be tested
using proper statistical principles [46] before sound
conclusions can be drawn.
Complexity
Further, showing patient age on one time axis with
causes of death resulted in discussion regarding
treatment-related deaths, quality of life, and patient
centeredness:
“It is almost a philosophical question—what is best to
die from? Heart failure due to a tough treatment or to
die a few months later because we have not been able
to control the cancer?”
– Process owner 3
“Then she spent seven weeks at the hospital to undergo
the treatment, instead of being home.”
– Process owner 4
“Then comes the question what the patient wants as
well. Most [patients] say that I know it is a tough
treatment but try to remove the cancer. But if they
knew that they would die because they had so much
nuisance, they might have said something else if one
would rewind some months.”
– Process owner 3
“But this is very important to highlight, how one
interprets this data. How one thinks, want to think.
How one sorts, consciously, unconsciously.”
– Process owner 4Uterine corpus sarcoma: within-diagram stratification of
sarcoma types
The idea to visualize all corpus cancer patients stratified
in two cohorts by tumor morphology using different line
colors had to be abandoned. As over 250 patients are
diagnosed with corpus cancer each year and the two
cohorts were well mixed over time, the diagram got
cluttered and impossible to interpret due to overlapping
lines.
Fig. 5 Lifelines for patients with cervical cancer Figo stages IB2–IIB. 5a. Lexis diagram showing diagnosis year vs years from diagnosis. Incidence
per year is equal to the number of patients in the cohort each year. 5b. Lexis diagram showing diagnosis year vs. patient age, with the same
dataset and legends as 5a
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coma, and stromal cell sarcoma) is a group of rare tu-
mors striking about 10 patients in Western Sweden
yearly. Leiomyosarcoma is regarded as the most severe
type of uterine corpus sarcomas; to assess this, a Lexisdiagram was produced separating the sarcomas through
different-colored lifelines. Besides the three main types
of sarcomas, the quality registry also considered other
sarcoma, other morphology, and no data (missing data);
see legend in Fig. 6.
Fig. 6 Lexis diagram of uterine corpus sarcomas with lines colored according to sarcoma type. Same-colored lines and dots represent deaths
caused by sarcoma; different colored dots and lines represent other causes of death or missing data, see legend. Seven patients diagnosed with
uterine corpus sarcomas did not receive surgery. Number of patients w. surgery per year is equal to the number of patients that underwent
surgery in the cohort each year
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Even more than cervical cancer, sarcoma is difficult to
analyze statistically due to very low incidence, reaffirm-
ing the need to visualize individual patient data for
timely feedback on trends, until statistical analysis can
be pursued.
Feedback by following data over time
Different-colored lines in Fig. 6 show the distribution of
different sarcoma types, where the lines or dots repre-
senting deaths per sarcoma type were counted. As
expected, many deaths are due to leiomyosarcoma, but
stromal cell sarcoma seems to kill proportionally more
(about half) of patients than leiomyosarcoma (about a
third).
Complexity
The description of complexity is here focused on
highlighting the different sarcoma types and identifica-
tion of the patients with tumor disease as cause of death.
This is made possible by highlighting these patients
using same-colored dots and lines, thus easilydifferentiating the deaths caused by the different sarco-
mas. Additionally, a few patients died from other causes
of death highlighted by different coloring between line
and dot, such as one patient with leiomyosarcoma who
died tumor free from another cause (red line, purple
dot). Moreover, missing cause of death (grey dot) high-
lights data quality issues.
Discussion
Dialogue with process owners indicated that Lexis dia-
grams are useful for survival data analysis. Process
owners highlighted the potential of Lexis diagrams for
both individual and population-level data [33], including
using the visualization to build testable hypotheses [8].
Further, feedback by following data over time, timeli-
ness, and complexity were recognized as prominent fea-
tures in QI for survival data.
Feedback by following data over time and timeliness
As new patients, patient events, and attribute data can
be added in real time, Lexis diagrams enable continuous
monitoring of and feedback on care processes, which are
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trends rather than significant changes, process owners
saw the results only as early indicators and real-time
feedback for timely evaluation of care (which may sup-
port hypothesis-testing using statistical analysis), which
they saw as valuable despite its lack of statistical signifi-
cance. Earlier research confirms the importance of feed-
back [12, 48] in QI. Data visualization seemed to be an
important driver, as some analysis, such as deaths due to
sarcomas, could have been analyzed in tabular form also,
but data visualization was still preferred by most process
owners, reflecting the power of visualization [49].Complexity
The diagrams’ ability to capture some of the complexity of
care was appreciated, and using different perspectives for
the three sub-diagnoses revealed the diagrams’ versatility.
Building up complexity iteratively as process owners
learned more about the Lexis diagrams, rather than in-
cluding all complexity initially, probably helped learning
[50]. The possibility of using different markings and colors
for lifelines and attribute data or changing time axes to
enhance visualization was useful to identify relevant pat-
terns. Still, only relevant factors should be included, to
avoid cluttering the diagram. This reflects QI theory,
which recommends simple graphical illustrations to aid
understanding [4], and visualization research, which ar-
gues for visualizations requiring minimal effort to inter-
pret, to enable sensemaking [8]. Note also that complexity
and understanding data are to some degree antipodean
[17]: the more complexity is included, the less the chance
of understanding the data. Therefore, a balance between
level of aspiration of understanding and complexity is
needed, driven by domain expertise. Basic Lexis diagrams
are mainly useful for small data sets [30], and large data
sets should preferably be analyzed using more advanced
Lexis diagrams [25, 26, 34].Additional insights on usefulness
The patient perspective
Visualization of individual patient lifelines increased
patient focus, which is important to QI [51], by
allowing process owners to understand individual
complexity. They moved beyond the narrow focus on
survival or death to see the patients behind the data
and their quality of life. Why did they die? What hap-
pened? How do they want to spend their last time?
Moreover, process owners saw potential to motivate
co-workers through increasing focus on the many
surviving patients, instead of focusing on the (gener-
ally) few that die. Earlier research confirms positive
effects of data feedback to increase motivation, pro-
vided the data are seen as trustworthy [52].Summarizing its perceived usefulness, the Lexis dia-
gram was not only useful to analyze data but also to
present data to decision-makers in care organizations to
support continuation or change of current practice and
to motivate colleagues. Inclusion of Lexis diagrams
within Swedish care organizations would be possible
through the existing platform in which regional patient
data are continuously updated and presented in various
ways. Lexis diagrams can be analyzed quarterly, which is
how frequently process owners normally use the plat-
form for data feedback.
Major drawbacks
It became apparent that caution is needed in incorp-
orating additional factors in the diagrams. As individ-
ual patient data are plotted, case-mix adjustment is
not an option; therefore, caution is needed when
interpreting data, so that differences in (e.g.) number
of dots each year are related to lifeline density, in this
study equal to the incidence rate of the disease. One
potential drawback with the basic Lexis diagram is
the possibility that intermediate events, such as re-
lapse, may affect how survival or the duration of the
disease is dependent on time [53]. In such a case, an
additional time axis in the Lexis diagram could be
used, rendering a 3D visualization [54].
Although process owners appreciated the option of
adding different markings and colors for attribute data,
too much information cluttered the diagram, making it
difficult or even impossible to interpret. This highlights
the need to show only relevant data [21], which may be
supported by interactive visualization, as exemplified in
Shneiderman et al. [55].
Limitations and future research
This study has some limitations. The survival data cover
only one type of diagnosis, in one part of Sweden, and
collaboration was conducted with only one group of
process owners. Still, by focusing on several sub-
diagnoses and analyzing different types of visualizations,
a broad view was given of the usefulness of Lexis
diagrams. As most insights were on a general QI level
rather than specific to gynecological cancer, meaningful
insights may result from attention to other contexts as
well.
As different types of Lexis diagrams and attribute data
were shown to be useful in different contexts and too
much information cluttered the visualization, future re-
search may strive to develop interactive Lexis diagram
platforms, enabling attribute data to be chosen depend-
ing on need and helping viewers understand the related-
ness of clinically relevant attribute datapoints [21].
These platforms could be extended to include 3D
visualization as well, to address secular time trends [54].
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while the process owners contributed with domain
knowledge, the iterative analysis increased the method
understanding among process owners over time. There-
fore, the process owners may have been somewhat
biased in their interpretation of the method’s usefulness
towards the end as compared to future novel users, and
it should be noted that education and experience may be
needed to fully grasp the method, preferably using an
interactive version of the Lexis diagram. Future research
on Lexis diagram usefulness is encouraged also to
present Lexis diagrams to practitioners not included in
the construction of the diagrams and gain insights about
their perceptions of Lexis diagram usefulness.
Finally, Lexis diagrams are not limited to survival data
but may be used for following any care process, just like
survival curves [16]. Future research can address the use
of Lexis diagrams for other diseases where feedback by
following data over time, timeliness, and complexity of
care are meaningful analytical criteria.
Conclusion
This study shows that Lexis diagrams can support QI,
through survival data analysis. By enabling continuous,
close-to-real-time data updating, Lexis diagrams were
shown to support timeliness, which is key to relevant
action for QI. Feedback, another important aspect of QI,
was enabled by following data over time, allowing under-
standing of trends and hypothesis-building based on
changes to the process. However, unlike Lexis diagrams,
survival curves include statistical significance testing,
and may therefore complement Lexis diagrams for
hypothesis-testing. Further, this study shows the
importance of analyzing the complexity of care pro-
cesses. Visualizing attribute data supports practitioners’
understanding of the care process, facilitating communica-
tion and triggering important dialogues between practi-
tioners and thereby supporting evaluation of given care or
identification of future QI efforts. However, since too much
data clutters visualization, confusing rather than supporting
understanding, it is important to include only relevant data,
presented in a clear way. The versatility of Lexis diagrams,
through different time axes, coloring, and markings, was
shown to be useful to address different questions and
analyze different perspectives on the care process.
One positive affordance of Lexis diagrams, linked to
both feedback and complexity, is the combined
visualization of individual and population levels. The
ability to see the individual patient as part of a popula-
tion not only supported understanding of the care
process but also facilitated increased focus on the pa-
tient’s needs. Shifting focus from deceased patients to in-
clude survivors may further affect motivation among
healthcare practitioners and management. The Lexisdiagram thereby has a non-overlapping potential appli-
cation compared to survival curves.
Care is needed, however, when using Lexis diagrams,
so that false conclusions are avoided, whether stemming
from bias toward a sub-group of patients, possible
variation in incidence rate, or visualizing data of ques-
tionable quality. These aspects may be addressed by
educating new users and reflecting on how data are pre-
sented in Lexis diagrams, through analyzing visualiza-
tions in close collaboration with care process experts.
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